AuthorThis press release accompanies both given a presentation and an ESC press conference at the ESC Congress 2008. Written by the investigator himself / herself, has reviewed this news release. Do not necessarily reflect the views of the European Society of Cardiology.Study of the specific properties to the antibacterial molecule currently in progress laboratory. We hope these molecules would finally to care for E. Coli and MRSA infections are increasing increasingly resistant to current drug developed needed. Lee. These Last antibiotics could potentially alternatives to currently available drugs the be effective, but serious and unwanted side effects may be, he said.. Simon Lee, a graduate student that gives his work at the Society for General Microbiology the fall sitting at Nottingham, of how the groups Unidentified of eight different molecule the insect tissues who were toxic to bacterial. Those substances therapy for treatments for multi-drug resistant bacterial infections. The group found that tissue of the brain tissue of the brain and to the nervous system of the insects more than 90 percent of methicillin-resistant Staphylococcus aureus and Escherichia coli, without damage human cells was -.

Jonathan Garlick is also a a member of the Cell, Molecular & Developmental Biology Programme Faculty of Sackler School from Tufts and of director of the Center of Integrated of tissue engineering at Tufts School of Dental Medicine.